Search company, investor...

Vensica Therapeutics

vensica.com

Total Raised

$21.5M

Investors Count

Deal Terms

Funding, Valuation & Revenue

5 Fundings

Vensica Therapeutics has raised $21.5M over 5 rounds.

Vensica Therapeutics's latest funding round was a Series B - II for $3M on February 7, 2022.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
2/7/2022	Series B - II	$3M	Merz Therapeutics	$99M	0 FY undefined	6
11/1/2021	Series B	$99M	Subscribe to see more	$99M	0 FY undefined	10
9/28/2017	Series A	$99M	Subscribe to see more	$99M	0 FY undefined	10
7/19/2016	Seed	$99M	Subscribe to see more	$99M	0 FY undefined	10
	Other Investors		Subscribe to see more	$99M	0 FY undefined	0

Date	2/7/2022	11/1/2021	9/28/2017	7/19/2016
Round	Series B - II	Series B	Series A	Seed	Other Investors
Amount	$3M	$99M	$99M	$99M
Investors	Merz Therapeutics	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Valuation	$99M	$99M	$99M	$99M	$99M
Revenue	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined
Sources	6	10	10	10	0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.

Click Now. Join a live demo

Looking for a leg up on competitive, customer and technology insights?

CB Insights puts confidence and clarity into your most strategic decisions.

See how. Join a demo.

Trusted by the world's smartest companies to:

Predict emerging trends
See competitors' playbooks
Stalk the smart money
Identify tomorrow's challengers
Spot growing industries
Kill analyst data work

Let's see how we can help you!

Vensica Therapeutics Deal Terms

1 Deal Term

Vensica Therapeutics's deal structure is available for 1 funding round, including their Series A from September 28, 2017.

Round	Series A
Funding Date	$99M
Pre-Money Valuation
Post-Money Valuation
Amount Raised	$99M
Shares Authorized
Issuance Price
Dividend Rate
Liquidation Preferences
Liquidation Price
Participation
Conversion Price
Anti Dilution
General Voting	$99M
Board Voting	$99M
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Series A	$99M			$99M									$99M	$99M